Published in Appl Environ Microbiol on April 01, 2005
Phage treatment of human infections. Bacteriophage (2011) 2.77
The recombinant phage lysin LysK has a broad spectrum of lytic activity against clinically relevant staphylococci, including methicillin-resistant Staphylococcus aureus. J Bacteriol (2005) 1.63
Bacteriophage cocktail for the prevention of biofilm formation by Pseudomonas aeruginosa on catheters in an in vitro model system. Antimicrob Agents Chemother (2009) 1.62
The Staphylococci phages family: an overview. Viruses (2012) 1.41
Glycosylation of wall teichoic acid in Staphylococcus aureus by TarM. J Biol Chem (2010) 1.29
First complete genome sequence of two Staphylococcus epidermidis bacteriophages. J Bacteriol (2006) 1.21
Characterization and comparative genomic analysis of a novel bacteriophage, SFP10, simultaneously inhibiting both Salmonella enterica and Escherichia coli O157:H7. Appl Environ Microbiol (2011) 1.11
Isolation from sewage influent and characterization of novel Staphylococcus aureus bacteriophages with wide host ranges and potent lytic capabilities. Appl Environ Microbiol (2009) 1.09
The role of regulated clinical trials in the development of bacteriophage therapeutics. J Mol Genet Med (2012) 1.01
In silico and in vivo evaluation of bacteriophage phiEF24C, a candidate for treatment of Enterococcus faecalis infections. Appl Environ Microbiol (2008) 0.99
Wide host range and strong lytic activity of Staphylococcus aureus lytic phage Stau2. Appl Environ Microbiol (2010) 0.97
In vitro activity against Staphylococcus aureus of a novel antimicrobial agent, PRF-119, a recombinant chimeric bacteriophage endolysin. Antimicrob Agents Chemother (2011) 0.96
Romulus and Remus, two phage isolates representing a distinct clade within the Twortlikevirus genus, display suitable properties for phage therapy applications. J Virol (2013) 0.95
A novel bacteriophage Tail-Associated Muralytic Enzyme (TAME) from Phage K and its development into a potent antistaphylococcal protein. BMC Microbiol (2011) 0.92
Efficacy of polyvalent bacteriophage P-27/HP to control multidrug resistant Staphylococcus aureus associated with human infections. Curr Microbiol (2010) 0.92
Two Phages, phiIPLA-RODI and phiIPLA-C1C, Lyse Mono- and Dual-Species Staphylococcal Biofilms. Appl Environ Microbiol (2015) 0.87
Improving the safety of Staphylococcus aureus polyvalent phages by their production on a Staphylococcus xylosus strain. PLoS One (2014) 0.85
Complete genome sequence of wide-host-range Staphylococcus aureus phage JD007. J Virol (2012) 0.85
Genome analysis of the staphylococcal temperate phage DW2 and functional studies on the endolysin and tail hydrolase. Bacteriophage (2014) 0.83
Strain Specific Phage Treatment for Staphylococcus aureus Infection Is Influenced by Host Immunity and Site of Infection. PLoS One (2015) 0.83
Bacteriophage Procurement for Therapeutic Purposes. Front Microbiol (2016) 0.82
Combined use of bacteriophage K and a novel bacteriophage to reduce Staphylococcus aureus biofilm formation. Appl Environ Microbiol (2014) 0.82
Potential of bacteriophage ΦAB2 as an environmental biocontrol agent for the control of multidrug-resistant Acinetobacter baumannii. BMC Microbiol (2013) 0.82
Biocontrol and Rapid Detection of Food-Borne Pathogens Using Bacteriophages and Endolysins. Front Microbiol (2016) 0.82
Characterization of novel Staphylococcus aureus lytic phage and defining their combinatorial virulence using the OmniLog® system. Bacteriophage (2016) 0.77
Isolation of a Novel Phage with Activity against Streptococcus mutans Biofilms. PLoS One (2015) 0.77
Bacteriophage K for reduction of Staphylococcus aureusbiofilm on central venous catheter material. Bacteriophage (2013) 0.77
Crystallization of the CHAP domain of the endolysin from Staphylococcus aureus bacteriophage K. Acta Crystallogr Sect F Struct Biol Cryst Commun (2013) 0.77
Isolation and Genome Characterization of the Virulent Staphylococcus aureus Bacteriophage SA97. Viruses (2015) 0.76
Phage Therapy: Future Inquiries. Postdoc J (2013) 0.75
Prospects of Phage Application in the Treatment of Acne Caused by Propionibacterium acnes. Front Microbiol (2017) 0.75
Isolation, Characterization, and Antibacterial Activity of Bacteriophages Against Methicillin-Resistant Staphylococcus aureus in Pakistan. Jundishapur J Microbiol (2016) 0.75
Characterization and formulation into solid dosage forms of a novel bacteriophage lytic against Klebsiella oxytoca. PLoS One (2017) 0.75
The emergence and evolution of methicillin-resistant Staphylococcus aureus. Trends Microbiol (2001) 7.73
Methicillin-resistant Staphylococcus aureus in Europe, 1999-2002. Emerg Infect Dis (2004) 6.00
Antimicrobial resistance: the example of Staphylococcus aureus. J Clin Invest (2003) 5.33
Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance. Lancet Infect Dis (2001) 5.28
Bacteriophage therapy. Antimicrob Agents Chemother (2001) 5.16
The economic impact of Staphylococcus aureus infection in New York City hospitals. Emerg Infect Dis (1999) 3.19
The prospect for bacteriophage therapy in Western medicine. Nat Rev Drug Discov (2003) 2.59
The serological differentiation of staphylococcal bacteriophages. J Gen Microbiol (1949) 2.45
Bacteriophages show promise as antimicrobial agents. J Infect (1998) 2.16
Phage therapy: past history and future prospects. Arch Immunol Ther Exp (Warsz) (1999) 2.10
Genome of staphylococcal phage K: a new lineage of Myoviridae infecting gram-positive bacteria with a low G+C content. J Bacteriol (2004) 2.08
Experimental protection of mice against lethal Staphylococcus aureus infection by novel bacteriophage phi MR11. J Infect Dis (2003) 2.06
Fine-structure molecular epidemiological analysis of Staphylococcus aureus recovered from cows. Epidemiol Infect (1997) 1.92
Evaluation of a cocktail of three bacteriophages for biocontrol of Escherichia coli O157:H7. Appl Environ Microbiol (2004) 1.87
The classification of bacteriophages lysing staphylococci. J Hyg (Lond) (1956) 1.85
A prospective audit of complex wound and graft infections in Great Britain and Ireland: the emergence of MRSA. Eur J Vasc Endovasc Surg (2001) 1.54
The purification and electron microscopical examination of the structure of staphylococcal bacteriophage K. J Gen Microbiol (1954) 1.44
Novel type I restriction specificities through domain shuffling of HsdS subunits in Lactococcus lactis. Mol Microbiol (2000) 1.15
Protection against Staphylococcus aureus mastitis in dairy cows using a bismuth-based teat seal containing the bacteriocin, lacticin 3147. J Dairy Sci (2000) 1.08
Phage antibacterials make a comeback. Nat Biotechnol (2001) 1.05
Bacteriophages: potential treatment for bacterial infections. BioDrugs (2002) 1.03
The new antibiotics. Nat Biotechnol (1999) 1.00
The morphology of staphylococcal bacteriophage K and DNA metabolism in infected Staphylococcus aureus. J Gen Virol (1981) 0.99
The influence of acridines on the interaction of Staphylococcus aureus and staphylococcus K phage. J Gen Microbiol (1951) 0.96
Molecular epidemiology of selected multidrug-resistant bacteria: a global report from the SENTRY Antimicrobial Surveillance Program. Diagn Microbiol Infect Dis (2004) 0.95
Motif-dependent DNA analysis of a methicillin-resistant Staphylococcus aureus collection. Br J Biomed Sci (1998) 0.89
THE KINETICS OF THE BACTERIUM-BACTERIOPHAGE REACTION. J Gen Physiol (1930) 0.87
Structure and properties of the rapidly sedimenting replicating complex of staphylococcal phage K DNA. J Gen Virol (1983) 0.85
The natural food grade inhibitor, lacticin 3147, reduced the incidence of mastitis after experimental challenge with Streptococcus dysgalactiae in nonlactating dairy cows. J Dairy Sci (1999) 0.80
Generation of restriction map of Enterococcus faecalis OG1 and investigation of growth requirements and regions encoding biosynthetic function. J Bacteriol (1993) 4.14
Lantibiotics: structure, biosynthesis and mode of action. FEMS Microbiol Rev (2001) 2.69
Sequence and analysis of the 60 kb conjugative, bacteriocin-producing plasmid pMRC01 from Lactococcus lactis DPC3147. Mol Microbiol (1998) 2.61
Species and type phages of lactococcal bacteriophages. Intervirology (1991) 2.55
An application in cheddar cheese manufacture for a strain of Lactococcus lactis producing a novel broad-spectrum bacteriocin, lacticin 3147. Appl Environ Microbiol (1996) 2.45
A conjugative transposon (Tn919) in Streptococcus sanguis. Infect Immun (1985) 2.41
Genome of staphylococcal phage K: a new lineage of Myoviridae infecting gram-positive bacteria with a low G+C content. J Bacteriol (2004) 2.08
Identification of the Minimal Replicon of Lactococcus lactis subsp. lactis UC317 Plasmid pCI305. Appl Environ Microbiol (1990) 2.06
Food fermentations: role of microorganisms in food production and preservation. Int J Food Microbiol (1999) 1.98
The RofA binding site in Streptococcus pyogenes is utilized in multiple transcriptional pathways. J Bacteriol (2000) 1.94
Evaluation of a cocktail of three bacteriophages for biocontrol of Escherichia coli O157:H7. Appl Environ Microbiol (2004) 1.87
Small intestinal submucosa as a large diameter vascular graft in the dog. J Surg Res (1989) 1.86
Getting better with bifidobacteria. J Appl Microbiol (2005) 1.81
Bacteriophage defence systems in lactic acid bacteria. Antonie Van Leeuwenhoek (1999) 1.75
γ-Aminobutyric acid production by culturable bacteria from the human intestine. J Appl Microbiol (2012) 1.72
Cloning and DNA sequence analysis of two abortive infection phage resistance determinants from the lactococcal plasmid pNP40. Appl Environ Microbiol (1995) 1.71
Health implications of high dietary omega-6 polyunsaturated Fatty acids. J Nutr Metab (2012) 1.68
The recombinant phage lysin LysK has a broad spectrum of lytic activity against clinically relevant staphylococci, including methicillin-resistant Staphylococcus aureus. J Bacteriol (2005) 1.63
Improvement and optimization of two engineered phage resistance mechanisms in Lactococcus lactis. Appl Environ Microbiol (2001) 1.59
Lacticin 3147, a broad-spectrum bacteriocin which selectively dissipates the membrane potential. Appl Environ Microbiol (1998) 1.58
Market potential for probiotics. Am J Clin Nutr (2001) 1.50
Molecular characterization of lactococcal bacteriophage Tuc2009 and identification and analysis of genes encoding lysin, a putative holin, and two structural proteins. Appl Environ Microbiol (1994) 1.48
Lantibiotics produced by lactic acid bacteria: structure, function and applications. Antonie Van Leeuwenhoek (2002) 1.45
Detailed characterization and comparison of four lactic streptococcal bacteriophages based on morphology, restriction mapping, DNA homology, and structural protein analysis. Appl Environ Microbiol (1987) 1.44
Protein-sulfenic acid stabilization and function in enzyme catalysis and gene regulation. FASEB J (1993) 1.42
Development of a probiotic cheddar cheese containing human-derived Lactobacillus paracasei strains. Appl Environ Microbiol (1998) 1.40
Sequence analysis and characterization of phi O1205, a temperate bacteriophage infecting Streptococcus thermophilus CNRZ1205. Microbiology (1997) 1.39
AbiG, a genotypically novel abortive infection mechanism encoded by plasmid pCI750 of Lactococcus lactis subsp. cremoris UC653. Appl Environ Microbiol (1996) 1.34
Comparative survival rates of human-derived probiotic Lactobacillus paracasei and L. salivarius strains during heat treatment and spray drying. Appl Environ Microbiol (2000) 1.33
Life under stress: the probiotic stress response and how it may be manipulated. Curr Pharm Des (2008) 1.31
Evaluation of lacticin 3147 and a teat seal containing this bacteriocin for inhibition of mastitis pathogens. Appl Environ Microbiol (1998) 1.30
Potential of bacteriocin-producing lactic acid bacteria for improvements in food safety and quality. Biochimie (2002) 1.30
Extensive post-translational modification, including serine to D-alanine conversion, in the two-component lantibiotic, lacticin 3147. J Biol Chem (1999) 1.29
Direct in situ viability assessment of bacteria in probiotic dairy products using viability staining in conjunction with confocal scanning laser microscopy. Appl Environ Microbiol (2001) 1.29
The Lactococcal Plasmid pNP40 Encodes a Third Bacteriophage Resistance Mechanism, One Which Affects Phage DNA Penetration. Appl Environ Microbiol (1996) 1.26
Cloning and characterization of the determinant for abortive infection of bacteriophage from lactococcal plasmid pCI829. J Gen Microbiol (1991) 1.25
Six putative two-component regulatory systems isolated from Lactococcus lactis subsp. cremoris MG1363. Microbiology (2000) 1.24
Identification of int and attP on the genome of lactococcal bacteriophage Tuc2009 and their use for site-specific plasmid integration in the chromosome of Tuc2009-resistant Lactococcus lactis MG1363. Appl Environ Microbiol (1994) 1.22
Electrotransformation of industrial strains of Streptococcus thermophilus. J Appl Microbiol (1999) 1.22
Development of High-Frequency Delivery System for Transposon Tn919 in Lactic Streptococci: Random Insertion in Streptococcus lactis subsp. diacetylactis 18-16. Appl Environ Microbiol (1987) 1.22
Improved survival of Lactobacillus paracasei NFBC 338 in spray-dried powders containing gum acacia. J Appl Microbiol (2002) 1.21
Lacticin 3147 displays activity in buffer against gram-positive bacterial pathogens which appear insensitive in standard plate assays. Lett Appl Microbiol (1999) 1.21
CRISPR analysis of bacteriophage-insensitive mutants (BIMs) of industrial Streptococcus thermophilus--implications for starter design. J Appl Microbiol (2009) 1.20
Invited review: Lactobacillus helveticus--a thermophilic dairy starter related to gut bacteria. J Dairy Sci (2010) 1.19
Cloning and characterization of the tetracycline resistance determinant of and several promoters from within the conjugative transposon Tn919. Appl Environ Microbiol (1988) 1.19
Improved stress tolerance of GroESL-overproducing Lactococcus lactis and probiotic Lactobacillus paracasei NFBC 338. Appl Environ Microbiol (2004) 1.17
Molecular characterization of a phage-encoded resistance system in Lactococcus lactis. Appl Environ Microbiol (1999) 1.17
Microbial solutions to microbial problems; lactococcal bacteriocins for the control of undesirable biota in food. J Appl Microbiol (2005) 1.16
Genomic diversity and relatedness of bifidobacteria isolated from a porcine cecum. J Bacteriol (2003) 1.15
Novel type I restriction specificities through domain shuffling of HsdS subunits in Lactococcus lactis. Mol Microbiol (2000) 1.15
Overcoming the technological hurdles in the development of probiotic foods. J Appl Microbiol (2005) 1.13
Characterization and heterologous expression of the genes encoding enterocin a production, immunity, and regulation in Enterococcus faecium DPC1146. Appl Environ Microbiol (1999) 1.13
Conjugated linoleic acid biosynthesis by human-derived Bifidobacterium species. J Appl Microbiol (2003) 1.13
Bacteriolytic activity caused by the presence of a novel lactococcal plasmid encoding lactococcins A, B, and M. Appl Environ Microbiol (1995) 1.13
Naturally occurring lactococcal plasmid pAH90 links bacteriophage resistance and mobility functions to a food-grade selectable marker. Appl Environ Microbiol (2001) 1.12
ScrFI restriction-modification system of Lactococcus lactis subsp. cremoris UC503: cloning and characterization of two ScrFI methylase genes. Appl Environ Microbiol (1993) 1.12
Identification and overexpression of ltnl, a novel gene which confers immunity to the two-component lantibiotic lacticin 3147. Microbiology (2000) 1.11
Biotechnology of lactic acid bacteria with special reference to bacteriophage resistance. Antonie Van Leeuwenhoek (1996) 1.11
Sources of the adventitious microflora of a smear-ripened cheese. J Appl Microbiol (2006) 1.10
Survival of probiotic lactobacilli in acidic environments is enhanced in the presence of metabolizable sugars. Appl Environ Microbiol (2005) 1.09
Molecular organization of the minimal replicon of novel, narrow-host-range, lactococcal plasmid pCI305. Plasmid (1991) 1.09
Each peptide of the two-component lantibiotic lacticin 3147 requires a separate modification enzyme for activity. Microbiology (2000) 1.08
Protection against Staphylococcus aureus mastitis in dairy cows using a bismuth-based teat seal containing the bacteriocin, lacticin 3147. J Dairy Sci (2000) 1.08
Catabolism of branched-chain alpha-keto acids in Enterococcus faecalis: the bkd gene cluster, enzymes, and metabolic route. J Bacteriol (1999) 1.08
Isolation and characterization of anti-Salmonella lactic acid bacteria from the porcine gastrointestinal tract. Lett Appl Microbiol (2004) 1.08
Intrinsic tolerance of Bifidobacterium species to heat and oxygen and survival following spray drying and storage. J Appl Microbiol (2005) 1.06
Utility of intra-access pressure monitoring in detecting and correcting venous outlet stenoses prior to thrombosis. Kidney Int (1995) 1.05
Inhibition of bacteriophage K proliferation on Staphylococcus aureus in raw bovine milk. Lett Appl Microbiol (2005) 1.05
Identification of four loci isolated from two Streptococcus thermophilus phage genomes responsible for mediating bacteriophage resistance. FEMS Microbiol Lett (2000) 1.03
Metabolic activities and probiotic potential of bifidobacteria. Int J Food Microbiol (2011) 1.03
Comparative survival of probiotic lactobacilli spray-dried in the presence of prebiotic substances. J Appl Microbiol (2004) 1.03
Rapid screening method for analyzing the conjugated linoleic acid production capabilities of bacterial cultures. Appl Environ Microbiol (2007) 1.03